The purpose of this study is to determine the proportion of subjects who have sufficient
improvement in ventricular function after undergoing a standardized Left Ventricular Assist
Device (LVAD) plus pharmacologic recovery treatment and testing protocol to allow removal of
the LVAD within 18 months.